Table 4.
Characteristics | Both aOR (95%CI) |
GCD alone aOR (95%CI) |
GCT alone aOR (95%CI) |
---|---|---|---|
Sex (ref = Female) | |||
Male | 1.21 (0.85–1.72) | 1.10 (0.72–1.66) | 0.888 (0.63–1.23) |
Age (ref = >60) | |||
≤60 | 0.88 (0.64–1.22) | 0.81 (0.55–1.19) | 0.98 (0.72–1.34) |
Pathological type (ref = Others) | |||
LUAD | 14.54 (6.79–31.12)*** | 16.29 (5.30–50.08)*** | 0.88 (0.56–1.39) |
LUSC | 12.91 (5.55–30.02)*** | 13.58 (4.13–44.74)*** | 0.81 (0.45–1.47) |
Stage (ref =IV) | |||
I | 39.13 (10.35–68.42)*** | 34.17 (18.72–97.05)*** | 22.86 (14.46–36.15)*** |
II | 6.75 (3.27–13.92)*** | 17.91 (5.88–54.58)*** | 2.24 (1.36–3.72)*** |
III | 10.04 (4.90–20.58)*** | 30.60 (10.14–92.32)*** | 1.99 (1.16–3.39)*** |
Area (ref = Rural) | |||
Urban | 0.86 (0.62–1.20) | 0.98 (0.66–1.45) | 1.03 (0.75–1.41) |
Oncology Specialist Hospital (ref = No) | |||
yes | 26.95 (14.20–51.17)*** | 15.84 (8.00–31.35)*** | 0.78 (0.35–1.72) |
aOR, adjusted odds ratio.
***P < 0.001.